O	0	9	Urokinase	Urokinase	NN	B-NP
O	10	18	receptor	receptor	NN	I-NP
O	18	19	:	:	:	O
O	20	21	a	a	DT	B-NP
O	22	31	molecular	molecular	JJ	I-NP
O	32	41	organizer	organizer	NN	I-NP
O	42	44	in	in	IN	B-PP
B-Cell	45	53	cellular	cellular	JJ	B-NP
O	54	67	communication	communication	NN	I-NP
O	67	68	.	.	.	O

O	69	71	In	In	IN	B-PP
O	72	73	a	a	DT	B-NP
O	74	81	variety	variety	NN	I-NP
O	82	84	of	of	IN	B-PP
B-Cell	85	89	cell	cell	NN	B-NP
O	90	95	types	type	NNS	I-NP
O	95	96	,	,	,	O
O	97	100	the	the	DT	B-NP
O	101	111	glycolipid	glycolipid	NN	I-NP
O	111	112	-	-	HYPH	B-VP
O	112	120	anchored	anchor	VBN	B-NP
O	121	130	urokinase	urokinase	NN	I-NP
O	131	139	receptor	receptor	NN	I-NP
O	140	141	(	(	(	O
O	141	145	uPAR	uPAR	NN	B-NP
O	145	146	)	)	)	O
O	147	149	is	be	VBZ	B-VP
O	150	161	colocalized	colocalize	VBN	I-VP
B-Immaterial_anatomical_entity	162	176	pericellularly	pericellularly	RB	B-ADVP
O	177	181	with	with	IN	B-PP
O	182	192	components	component	NNS	B-NP
O	193	195	of	of	IN	B-PP
O	196	199	the	the	DT	B-NP
O	200	211	plasminogen	plasminogen	NN	I-NP
O	212	222	activation	activation	NN	I-NP
O	223	229	system	system	NN	I-NP
O	230	233	and	and	CC	I-NP
O	234	245	endocytosis	endocytosis	NN	I-NP
O	246	255	receptors	receptor	NNS	I-NP
O	255	256	.	.	.	O

O	257	261	uPAR	uPAR	NN	B-NP
O	262	264	is	be	VBZ	B-VP
O	265	269	also	also	RB	I-VP
O	270	281	coexpressed	coexpresse	VBN	I-VP
O	282	286	with	with	IN	B-PP
O	287	295	caveolin	caveolin	NN	B-NP
O	296	299	and	and	CC	I-NP
O	300	307	members	member	NNS	I-NP
O	308	310	of	of	IN	B-PP
O	311	314	the	the	DT	B-NP
O	315	323	integrin	integrin	NN	I-NP
O	324	332	adhesion	adhesion	NN	I-NP
O	333	341	receptor	receptor	NN	I-NP
O	342	353	superfamily	superfamily	NN	I-NP
O	353	354	.	.	.	O

O	355	358	The	The	DT	B-NP
O	359	368	formation	formation	NN	I-NP
O	369	371	of	of	IN	B-PP
O	372	382	functional	functional	JJ	B-NP
O	383	388	units	unit	NNS	I-NP
O	389	393	with	with	IN	B-PP
O	394	399	these	these	DT	B-NP
O	400	407	various	various	JJ	I-NP
O	408	416	proteins	protein	NNS	I-NP
O	417	423	allows	allow	VBZ	B-VP
O	424	427	the	the	DT	B-NP
O	428	432	uPAR	uPAR	NN	I-NP
O	433	435	to	to	TO	B-VP
O	436	443	mediate	mediate	VB	I-VP
O	444	447	the	the	DT	B-NP
O	448	455	focused	focus	VBN	I-NP
O	456	467	proteolysis	proteolysis	NN	I-NP
O	468	476	required	require	VBN	B-VP
O	477	480	for	for	IN	B-PP
B-Cell	481	485	cell	cell	NN	B-NP
O	486	495	migration	migration	NN	I-NP
O	496	499	and	and	CC	O
O	500	508	invasion	invasion	NN	B-NP
O	509	512	and	and	CC	O
O	513	515	to	to	TO	B-VP
O	516	526	contribute	contribute	VB	I-VP
O	527	531	both	both	DT	O
O	532	540	directly	directly	RB	B-ADVP
O	541	544	and	and	CC	O
O	545	555	indirectly	indirectly	RB	B-ADVP
O	556	558	to	to	TO	B-PP
B-Cell	559	563	cell	cell	NN	B-NP
O	564	572	adhesive	adhesive	JJ	I-NP
O	573	582	processes	process	NNS	I-NP
O	583	585	in	in	IN	B-PP
O	586	587	a	a	DT	B-NP
O	588	591	non	non	AFX	I-NP
O	591	592	-	-	HYPH	I-NP
O	592	603	proteolytic	proteolytic	JJ	I-NP
O	604	611	fashion	fashion	NN	I-NP
O	611	612	.	.	.	O

O	613	617	This	This	DT	B-NP
O	618	622	dual	dual	JJ	I-NP
O	623	631	activity	activity	NN	I-NP
O	631	632	,	,	,	O
O	633	641	together	together	RB	B-ADVP
O	642	646	with	with	IN	B-PP
O	647	650	the	the	DT	B-NP
O	651	661	initiation	initiation	NN	I-NP
O	662	664	of	of	IN	B-PP
O	665	671	signal	signal	NN	B-NP
O	672	684	transduction	transduction	NN	I-NP
O	685	693	pathways	pathway	NNS	I-NP
O	694	696	by	by	IN	B-PP
O	697	701	uPAR	uPAR	NN	B-NP
O	701	702	,	,	,	O
O	703	705	is	be	VBZ	B-VP
O	706	714	believed	believe	VBN	I-VP
O	715	717	to	to	TO	I-VP
O	718	727	influence	influence	VB	I-VP
B-Cell	728	736	cellular	cellular	JJ	B-NP
O	737	746	behaviour	behaviour	NN	I-NP
O	747	749	in	in	IN	B-PP
O	750	762	angiogenesis	angiogenesis	NN	B-NP
O	762	763	,	,	,	O
O	764	776	inflammation	inflammation	NN	B-NP
O	776	777	,	,	,	O
B-Pathological_formation	778	783	wound	wound	NN	B-NP
O	784	790	repair	repair	NN	I-NP
O	791	794	and	and	CC	O
B-Cancer	795	800	tumor	tumor	NN	B-NP
O	801	812	progression	progression	NN	I-NP
O	812	813	/	/	SYM	B-NP
O	813	823	metastasis	metastasis	NN	I-NP
O	824	827	and	and	CC	O
O	828	832	open	open	VB	B-VP
O	833	835	up	up	RP	B-PRT
O	836	839	the	the	DT	B-NP
O	840	843	way	way	NN	I-NP
O	844	847	for	for	IN	B-PP
O	848	852	uPAR	uPAR	NN	B-NP
O	852	853	-	-	HYPH	O
O	853	858	based	base	VBN	B-NP
O	859	870	therapeutic	therapeutic	JJ	I-NP
O	871	881	approaches	approach	NNS	I-NP
O	881	882	.	.	.	O

